Similar articles for PMID: 27466548

Year	Number of Results
2008	1
2012	10
2013	9
2014	11
2015	41
2016	60
2017	65
2018	64
2019	67
2020	61
2021	42
2022	34
2023	9
2024	0

1

Efficacy and Safety of Regorafenib or TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies.

Sueda T, Sakai D, Kudo T, Sugiura T, Takahashi H, Haraguchi N, Nishimura J, Hata T, Hayashi T, Mizushima T, Doki Y, Mori M, Satoh T. Sueda T, et al. Anticancer Res. 2016 Aug;36(8):4299-306. Anticancer Res. 2016. PMID: 27466548

2

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.

Masuishi T, Taniguchi H, Hamauchi S, Komori A, Kito Y, Narita Y, Tsushima T, Ishihara M, Todaka A, Tanaka T, Yokota T, Kadowaki S, Machida N, Ura T, Fukutomi A, Ando M, Onozawa Y, Tajika M, Yasui H, Muro K, Mori K, Yamazaki K. Masuishi T, et al. Clin Colorectal Cancer. 2017 Jun;16(2):e15-e22. doi: 10.1016/j.clcc.2016.07.019. Epub 2016 Aug 31. Clin Colorectal Cancer. 2017. PMID: 27670892

3

Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.

Huemer F, Schlintl V, Hecht S, Hackl H, Melchardt T, Rinnerthaler G, Greil R, Weiss L. Huemer F, et al. Clin Colorectal Cancer. 2019 Jun;18(2):159-166.e3. doi: 10.1016/j.clcc.2019.04.003. Epub 2019 Apr 11. Clin Colorectal Cancer. 2019. PMID: 31060856 Free article.

4

Regorafenib, TAS-102, or fruquintinib for metastatic colorectal cancer: any difference in randomized trials?

Zhang Q, Wang Q, Wang X, Li J, Shen L, Peng Z. Zhang Q, et al. Int J Colorectal Dis. 2020 Feb;35(2):295-306. doi: 10.1007/s00384-019-03477-x. Epub 2019 Dec 17. Int J Colorectal Dis. 2020. PMID: 31848739

5

Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution.

Kotani D, Shitara K, Kawazoe A, Fukuoka S, Kuboki Y, Bando H, Okamoto W, Kojima T, Doi T, Ohtsu A, Yoshino T. Kotani D, et al. Clin Colorectal Cancer. 2016 Sep;15(3):e109-15. doi: 10.1016/j.clcc.2015.11.005. Epub 2015 Nov 27. Clin Colorectal Cancer. 2016. PMID: 26723516

6

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer.

Sonbol MB, Benkhadra R, Wang Z, Firwana B, Walden DJ, Mody K, Hubbard JM, Murad MH, Ahn DH, Bekaii-Saab T. Sonbol MB, et al. Oncologist. 2019 Sep;24(9):1174-1179. doi: 10.1634/theoncologist.2019-0189. Epub 2019 Jun 4. Oncologist. 2019. PMID: 31164455 Free PMC article.

7

Efficacy and Safety of TAS-102 in Clinical Practice of Salvage Chemotherapy for Metastatic Colorectal Cancer.

Arita S, Shirakawa T, Matsushita Y, Shimokawa HK, Hirano G, Makiyama A, Shibata Y, Tamura S, Esaki T, Mitsugi K, Ariyama H, Kusaba H, Akashi K, Baba E. Arita S, et al. Anticancer Res. 2016 Apr;36(4):1959-66. Anticancer Res. 2016. PMID: 27069187

8

Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102.

Bekir Hacioglu M, Kostek O, Kurt N, Kucukarda A, Gokyer A, Ustabasioglu FE, Karatas F, Tuncbilek N, Uzunoglu S, Bilici A, Cicin I, Erdogan B. Bekir Hacioglu M, et al. J BUON. 2019 Sep-Oct;24(5):2198-2204. J BUON. 2019. PMID: 31786894 Free article.

9

Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.

Unseld M, Drimmel M, Siebenhüner A, Gleiss A, Bianconi D, Kieler M, Scheithauer W, Winder T, Prager GW. Unseld M, et al. Clin Colorectal Cancer. 2018 Dec;17(4):274-279. doi: 10.1016/j.clcc.2018.05.012. Epub 2018 Jun 8. Clin Colorectal Cancer. 2018. PMID: 30042010

10

Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data.

Vitale P, Zanaletti N, Famiglietti V, De Falco V, Cervantes A, Rosellò S, Fenocchio E, Milanesio M, Lombardi P, Ciardiello D, Martini G, Martinelli E, Ciardiello F, Troiani T, Napolitano S. Vitale P, et al. Clin Colorectal Cancer. 2021 Sep;20(3):227-235. doi: 10.1016/j.clcc.2021.06.002. Epub 2021 Jun 10. Clin Colorectal Cancer. 2021. PMID: 34226142 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

412 results

Results by year